Abstract:Introduction: The COVID-19 pandemic has led to unforeseen and novel manifestations, as illustrated by the management of drug shortages through the development of hospital production of sterile pharmaceutical preparations (P2S). Visual inspection of P2S is a release control whose methods are described in monographs of the European Pharmacopoeia (2.9.20) and the United States Pharmacopeia (1790). However, these non-automated visual methods require training and proficiency testing of personnel. The main objective of this work was to compare the reliability and speed of analysis of two visual methods and an automated method for detecting visible particles by image analysis in P2S. Furthermore, these methods were used to evaluate sources of particulate contamination during pre-production processes (washing, disinfection, depyrogenation) and production (filling, capping). Materials and methods: Three pharmacy technicians examined 41 clear glass vials of type I, 10 and/or 50 mL through manual visual inspection (MVI), semi-automated (SAVI), and automated (AVI) inspection. The vials were distributed as follows: (i) 16 vials of water for injection containing either glass particles (224 µm or 600 µm), stopper fragments, or textile fibres; (ii) five sterile injectable specialties; (iii) 20 vials of water for injection prepared under different pre-production conditions. Results and discussion: MVI and SAVI detected 100% of visible particles compared with 28% for AVI, which showed a deficiency in detecting textile fibres. All three methods correctly analysed P2S that did not contain visible particles. The three methods detected particles in vials maintained under International Organization for Standardization (ISO) 9 pre-production conditions. However, detections by (i) MVI and SAVI, and by (ii) AVI of particles contained in vials maintained under ISO 8 pre-production conditions were deemed satisfactory and unsatisfactory, respectively. Conclusion: The importance of visual inspection of P2S requires rapid, sensitive, and reliable detection methods. In this context, MVI and SAVI have proven to be more effective than AVI for a more competitive financial, training, and implementation investment.

Mechanical Inclusions in Ophthalmic Drugs

Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis

Ophthalmic Drug Dosage Forms: Characterisation and Research Methods

Method for determination and element analysis of particulate contamination in injectable solutions

Evaluation of particle size distribution of sub-visible particles in powder injections with different packaging forms - small-sized sub-visible particles should not be ignored

[Determination of Enantiomeric Impurity of Timolol Maleate in Bulk Substances and Eye Drops].

Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components

Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications

Non-destructive Analysis of Subvisible Particles with Mie-scattering-based Light Sheet Technology: System Development

Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations

Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols

Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin

Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study

Ophthalmic and Otic Drug Administration: Novel Approaches and Challenges

An Insight into Ophthalmic Drug Delivery System

Evaluation of the quality of generic polymethylmethacrylate intraocular lenses marketed in India

What about generic glaucoma medications and the ocular surface?

Study of Insoluble Particles and Microorganism Contamination Produced by Clinical Use of Plastic and Glass Ampoules

Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations

Determination of ointments active ingredients and parabens by one analytical method – capillary GC with cool-on-column injection and FID detection

Particulate contamination in parenteral type medical devices